BRO vs ZVRA · P/E 30, rev $3.58B vs P/E 6.3, rev $75.9M
Brown & Brown Inc (BRO) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the BRO and ZVRA stock pages for the full models.
Not investment advice.